Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00531

By:

• Yongchuan Gu;
• Chang, Tony T.-A.;
• Jingli Wang;
• Jaiswal, Jagdish K.;
• Edwards, David;
• Downes, Noel J.;
• Liyanage, H. D. Sarath;
• Lynch, Courtney R. H.;
• Pruijn, Frederik B.;
• Hickey, Anthony J. R.;
• Hay, Michael P.;
• Wilson, William R.;
• Hicks, Kevin O.

Publication type:

Article